Biotech, medical device, and pharmaceutical company pioneers are represented by Schwabe.

industry relationships

Oregon Health and Sciences University

Oregon Bioscience Association

Association of University Technology Managers

What our clients say

‎”Schwabe has excellent patent attorneys, with outstanding technical depth and great business acumen, which ‎helps us make smart business decisions. Their work for us has always been high quality and their team has ‎consistently been available for time-sensitive issues. I strongly recommend the entire Schwabe team for ‎sophisticated IP work.”‎

Andrew Barofsky, President and CEO, RevMedx, Inc.

Experience

  • Defended against pharmaceutical and medical device claims for over 40 ‎years, representing manufacturers in individual cases, mass tort ‎litigation, and class action lawsuits.‎
  • Represent branded pharmaceutical companies in the preparation and prosecution of patent applications in the US and abroad directed to biopharmaceutical products including antibodies, bispecific and multispecific antigen-binding molecules, fusion proteins, chimeric antigen receptors, and AAVs, as well as formulations, and purification and characterization processes and assays.
  • Represent a research institution in the preparation and prosecution of patent applications directed to medical devices, diagnostics, therapeutics, drug delivery, and imaging.
  • Defended a medical device developer in multibillion-dollar infringement lawsuits. The favorable outcome included “exceptional case” determination and fee awards for our clients. 

  • Defended a global pharmaceutical manufacturer against product defect claims based upon novel “innovator liability” theory.

  • Represent research institutions, major universities, and medical schools in the preparation and prosecution of patent applications involving technologies ranging from medical ‎devices to diagnostics/assays to treatments to biochemical and pharmaceutical innovations.‎
  • Successfully defended a closely held company before the Oregon District Court in a patent infringement suit launched by a global medical device company, obtaining the reversal of an $85 million jury verdict against our client. 
  • Representing medical device manufacturer in competitor patent litigation involving partially implantable continuous glucose monitoring (CGM) sensor system for diabetes patients.
  • Represented medical device manufacturer in multiple competitor patent litigations regarding transducers, medical monitor design, and intravascular guide wire design.
  • Led the defense of a large generic pharmaceutical company in multiple patent suits brought by owners of branded pharmaceutical products under the Hatch-Waxman Act.
  • Obtained summary judgment of non-infringement for a large medical device company accused of infringing patents directed to a genetically modified reverse transcriptase.

Sign up

Ideas & Insights